|
受注:045-509-1970 |
技術サポート:tech@selleck.co.jp 平日9:00〜18:00 1営業日以内にご連絡を差し上げます |
|
Synonyms | Flagecidin, Wuningmeisu C | Storage (From the date of receipt) |
3 years -20°C powder 1 years -80°C in solvent |
|||
| 化学式 | C14H19NO4 |
||||||
| 分子量 | 265.3 | CAS No. | 22862-76-6 | ||||
| Solubility (25°C)* | 体外 | DMSO (warmed with 50ºC water bath) | 53 mg/mL (199.77 mM) | ||||
| Ethanol (warmed with 50ºC water bath) | 53 mg/mL (199.77 mM) | ||||||
| Water | 2 mg/mL (7.53 mM) | ||||||
| 体内 (毎回新しく調製した物を用意してください) |
|
||||||
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||||||
| 製品説明 | Anisomycin (Flagecidin, Wuningmeisu C) is a bacterial antibiotic isolated from Streptomyces griseolus, which inhibits protein synthesis, and also act as a JNK activator. Anisomycin upregulates autophagy and increases apoptosis. |
|---|---|
| in vitro | Anisomycin (3 μM) decreases protein synthesis in MDA16 and MDA-MB-468 cells, and reduces colony formation by MDA-MB-468 cells. This compound causes an increase in the number of apoptotic cells in MDA-MB-468 cultures, but not in MDA16 cultures. It actives JNK phosphorylation in MDA-MB-468 cells.[2] In U251 and U87 cells, this chemical (0.01-8 μM) inhibits the cell growth in time- and concentration-dependent manners with the IC50 (48 h) values of 0.233 and 0.192 μmol/L, respectively. It (4 μM) causes 21.5% and 25.3% of apoptosis proportion in U251 and U87 cells, respectively, and activates p38 MAPK and JNK, while inactivated ERK1/2. This compound (4 μM) reduces the level of PP2A/C subunit in a time-dependent manner in U251 and U87 cells.[3] It inhibits EAC cell proliferation in concentration-dependent manner.[4] |
| in vivo | Peritumoral administration of anisomycin (5 mg/kg) significantly suppresses Ehrlich ascites carcinoma (EAC) growth resulting in the survival of approximately 60% of the mice 90 days after EAC inoculation.[4] |
| キナーゼアッセイ | JNK phosphorylation | |
|---|---|---|
| 500,000 cells/well are seeded in 6-well plates and incubated overnight. Cells are then incubated for 1 h with test compounds or DMSO as vehicle control (final concentration 1% v/v). Puromycin is added (final concentration of 18 μM) and cells incubated for a further 10 min to label nascent polypeptide chains. Background labelling is determined by incubating cells without puromycin. Cells are then washed in HBSS, harvested by scraping and centrifuged (300 g, 5 min). Cells are resuspended in 0.5 mL 50 mM DTT containing phosphatase inhibitors and incubated at 95℃ for 10 min. Samples are then snap frozen in liquid nitrogen and stored at -20℃ until blotted. Samples (20–30 μg protein/sample) are blotted onto a PVDF membrane. The membrane is blocked and incubated with anti-phospho-Thr183/Tyr185-JNK antibody overnight at 4℃. Secondary antibodies are used to label the primary antibody and detected using an infrared scanner. The intensity of the fluorescence signal for anti-phospho-JNK antibody is background corrected and normalized for loading. | ||
| 細胞アッセイ | 細胞株 | Ehrlich ascites carcinoma (EAC) cells |
| 濃度 | 500 ng/mL | |
| 反応時間 | 48 h | |
| 実験の流れ | For the assay, EAC cells are plated in 96-well plates at a density of 10,000 cells/well/200 µL of medium. The cells are treated with the different concentrations of this compound for 48 h. Adriamycin (500 ng/mL) is used as a positive control. 0.5 mg/mL of MTT is added to each well. 4 h later, the formazan product of MTT reduction is dissolved in DMSO, and absorbance is measured at 570 nm using a Model 680 microplate reader. | |
| 動物実験 | 動物モデル | Male BALB/c mice |
| 投薬量 | 5 mg/kg | |
| 投与方法 | peritumorally | |
|

, , J Cell Biochem, 2017, 118(12):4905-4913

Data from [Data independently produced by , , Redox Biol, 2018, 14:59-71]

Data from [Data independently produced by , , Redox Biol, 2018, 14:576-587]
| Dominant interfering CARD11 variants disrupt JNK signaling to promote GATA3 expression in T cells [ J Exp Med, 2025, 222(6)e20240272] | PubMed: 40111223 |
| Disrupting AGR2/IGF1 paracrine and reciprocal signaling for pancreatic cancer therapy [ Cell Rep Med, 2025, 6(2):101927] | PubMed: 39914384 |
| AMBP protects against aortic valve calcification by inhibiting ERK1/2 and JNK pathways mediated by FHL3 [ Theranostics, 2025, 15(10):4398-4415] | PubMed: 40225558 |
| Portimine A toxin causes skin inflammation through ZAKα-dependent NLRP1 inflammasome activation [ EMBO Mol Med, 2025, 10.1038/s44321-025-00197-4] | PubMed: 39948420 |
| UFMylation safeguards human hepatocyte differentiation and liver homeostasis by regulating ribosome dissociation [ Cell Rep, 2025, 44(5):115686] | PubMed: 40347470 |
| sFRP5 ameliorates atherosclerosis by suppressing the JNK/TLR9 pathway in macrophages [ Transl Res, 2025, 281:1-13] | PubMed: 40409587 |
| GRASPs link Reelin to the Golgi during neocortical development to control neuronal migration and dendritogenesis [ Commun Biol, 2025, 8(1):572] | PubMed: 40188221 |
| PRDX1 knockdown promotes erastin-induced ferroptosis and impedes diffuse large B-cell lymphoma development by inhibiting the MAPK/ERK pathway [ BMC Cancer, 2025, 25(1):806] | PubMed: 40307771 |
| Promoter Methylation of WIF1 is Involved in IL-17-Induced Chondrocyte Inflammatory Injury and Matrix Degradation via Promoting Wnt5a/MAPK-JNK Signaling [ Mol Biotechnol, 2025, none] | PubMed: 40072748 |
| Transcriptional landscape and predictive potential of long noncoding RNAs in peritoneal recurrence of gastric cancer [ Mol Cancer, 2024, 23(1):284] | PubMed: 39736670 |
長期の保管のために-20°Cの下で製品を保ってください。
人間や獣医の診断であるか治療的な使用のためにでない。
各々の製品のための特定の保管と取扱い情報は、製品データシートの上で示されます。大部分のSelleck製品は、推薦された状況の下で安定です。製品は、推薦された保管温度と異なる温度で、時々出荷されます。長期の保管のために必要とされてそれと異なる温度で、多くの製品は、短期もので安定です。品質を維持するが、夜通しの積荷のために最も経済的な貯蔵状況を用いてあなたの送料を保存する状況の下に、製品が出荷されることを、我々は確実とします。製品の受領と同時に、製品データシートの上で貯蔵推薦に従ってください。